HomeBiotechnology

Biotechnology

CRISPR Therapeutics AG (CRSP) Stock Moves -0.09%: What You Should Know

CRISPR Therapeutics AG (CRSP) Stock Moves -0.09%: What You Should Know

June 27, 2022

Stocks Begin Week on Down Note

Stocks Begin Week on Down Note

June 27, 2022

Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation

Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation

June 27, 2022

Bristol Myers (BMY) Breyanzi Gets FDA Nod for Label Expansion

Bristol Myers (BMY) Breyanzi Gets FDA Nod for Label Expansion

June 27, 2022

Here’s Why Investors Should Retain CVS Health (CVS) For Now

Here’s Why Investors Should Retain CVS Health (CVS) For Now

June 27, 2022

Cheap Stocks To Buy Today? 3 Health Care Stocks For Your Watchlist

Cheap Stocks To Buy Today? 3 Health Care Stocks For Your Watchlist

June 27, 2022

BioMarin (BMRN) Gets CHMP Nod for Hemophilia Drug Roctavian

BioMarin (BMRN) Gets CHMP Nod for Hemophilia Drug Roctavian

June 27, 2022

Pfizer’s (PFE) Omicron-Based COVID Shot Betters Immune Response

Pfizer’s (PFE) Omicron-Based COVID Shot Betters Immune Response

June 27, 2022

Arvinas, Inc. (ARVN) Stock Jumps 8%: Will It Continue to Soar?

Arvinas, Inc. (ARVN) Stock Jumps 8%: Will It Continue to Soar?

June 27, 2022

BridgeBio Pharma Announces Positive Phase 1 Data and Phase 2/3 Trial Design for BBP-711, a Potentially Best-In-Class GO Inhibitor for Primary Hyperoxaluria Type 1 (PH1) and Recurrent Kidney Stone Formers

BridgeBio Pharma Announces Positive Phase 1 Data and Phase 2/3 Trial Design for BBP-711, a Potentially Best-In-Class GO Inhibitor for Primary Hyperoxaluria Type 1 (PH1) and Recurrent Kidney Stone Formers

June 27, 2022

« 1 … 29 30 31 32 33 … 543 »